Related Concept Videos
Cytomegalovirus Disease
Respiratory Syncytial Virus Disease
Vaccine Production
Poliomyelitis
You might also read
Related Articles
Articles linked to this work by shared authors, journal, and citation graph.
Cytomegalovirus Disease
Respiratory Syncytial Virus Disease
Vaccine Production
Poliomyelitis
You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Updated: Jul 3, 2026

Generation of Recombinant Arenavirus for Vaccine Development in FDA-Approved Vero Cells
Published on: August 1, 2013
1Division of Pediatric Infectious Diseases, Department of Pediatrics, Center for Infectious Diseases and Microbiology Translational Research, University of Minnesota Medical School, 2001 6th Street SE, Minneapolis, MN 55455, USA. schleiss@umn.edu
Developing a human cytomegalovirus (HCMV) vaccine remains challenging due to unclear immune correlates and target populations. Further research and public education are crucial for preventing HCMV disease.
Area of Science:
Background:
Purpose of the Study:
Main Methods:
Main Results:
Conclusions: